Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-07 | AGIOS PHARMACEUTICALS, INC. | Burns James William
(Chief Legal Officer) |
S | Common stock | D | 21752 | $52.00 - $52.56 | $1,135,774 |
| 2024-09-26 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
S | Common stock | D | 2542 | $49.03 - $49.03 | $124,634 |
| 2024-09-26 | AGIOS PHARMACEUTICALS, INC. | Jones Cecilia
(Chief Financial Officer) |
M | Common stock | A | 7473 | $0.00 - $0.00 | $0 |
| 2024-08-08 | AGIOS PHARMACEUTICALS, INC. | Goff Brian
(Chief Executive Officer) |
S | Common stock | D | 11091 | $42.75 - $42.75 | $474,140 |
| 2024-08-08 | AGIOS PHARMACEUTICALS, INC. | Goff Brian
(Chief Executive Officer) |
M | Common stock | A | 22691 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Foster-Cheek Kaye I
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Foster-Cheek Kaye I
(Director) |
G | Common stock | D | 3564 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | FOUSE JACQUALYN A
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Schenkein David P
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Ballal Rahul D.
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Ho Maykin
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Scadden David
(Director) |
M | Common stock | A | 3388 | $0.00 - $0.00 | $0 |
| 2024-06-13 | AGIOS PHARMACEUTICALS, INC. | Owen Catherine E.
(Director) |
M | Common stock | A | 1976 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |